非睡眠专家医生对失眠投诉的管理:法国DELPHI共识
Pierre-Alexis Geoffroy1,2,3, Jean-Louis Pépin4, Marjorie Guillet5
1Department of Psychiatry and Addictology, AP-HP, GHU Paris Nord, DMU Neurosciences, Bichat - Claude Bernard Hospital, Paris, France.
Journal of sleep research
|July 17, 2025
概括
法国Delphi共识为治理失眠障碍的全科医生提供了实际建议. 它为初级保健医生提供了一个框架,有效评估和治疗失眠患者,改善公共卫生结果.
科学领域:
- 睡眠医学 睡眠医学
- 一般实践 一般实践
- 公共卫生 公共卫生
背景情况:
- 失眠是一种普遍存在的睡眠障碍,影响生活质量和健康.
- 它经常被低诊断,并且在初级保健中管理不当.
- 由于时间和培训的限制,全科医生 (GPs) 在管理失眠方面面临挑战.
研究的目的:
- 为管理失眠障碍的非睡眠专家医生制定实际建议.
- 为失眠评估,评估,管理和转诊提供一个结构化的框架.
- 弥合专家指南和现实世界临床实践之间的差距.
主要方法:
- 进行了一项法国德尔菲共识研究.
- 一个多学科的指导委员会制定了21个临床陈述.
- 37名全科医生参加了两轮匿名评级,使用9分利克特等级.
主要成果:
- 在95%的声明中达成共识,这些声明涵盖了评估,睡眠卫生,行为干预和转诊.
- 引起争议的领域包括催眠药的处方,这表明需要进一步教育.
- 共识强调了对初级保健的务实,定制的方法.
结论:
- 德尔菲共识为治理失眠障碍的全科医生提供了一个灵活的框架.
- 它支持初级保健机构的基于证据的实用策略.
- 在初级保健中改善失眠障碍的管理可以改善公共卫生.
相关概念视频
Management of Insomnia
323
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
323
Insomnia
131
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
131
Sedatives and Hypnotics Drugs: Miscellaneous Agents
245
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
245
Narcolepsy
200
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
200
CNS Depressants: Barbiturates and Benzodiazepines
474
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
474
Sedatives and Hypnotics: Overview
659
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
659


